In addition, erastin combined with acetaminophen (APAP) inhibits NSCLC cell viability and promotes ferroptosis and apoptosis by suppressing Nrf2 nuclear translocation [175]. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.